Gürel Duygu, Ulukuş Çağnur, Karaçam Volkan, Ellidokuz Hülya, Umay Cenk, Öztop İlhan, Sarıoğlu Sülen
Department of Pathology, Dokuz Eylül University, Faculty of Medicine, Izmir, Turkey.
Department of Thoracic Surgery, Dokuz Eylül University, Faculty of Medicine, Izmir, Turkey.
Pathol Res Pract. 2016 Jan;212(1):1-9. doi: 10.1016/j.prp.2015.10.006. Epub 2015 Oct 31.
Novel histopathological prognostic features for squamous cell carcinoma (SCC) of lung, such as tumor budding, mitotic rate, tumor stroma ratio, stroma type, stromal inflammation and necrosis, have been evaluated in the literature. In this study, the prognostic value of multiple morphological features is assessed in lung SCC.
This study reports on seventy-six patients with lung SCC treated with complete surgical excision. Tumor size, tumor stage, lymph node status, lymphovascular invasion, histopathologic grade, mitotic count, necrosis, tumor budding, tumor stroma ratio, stroma type, stromal lymphoplasmacytic reaction and ratios of stromal plasma cells and their relationship with the prognosis were evaluated. Univariate and multivariate analyses were performed for histopathological markers for local disease free survival (LDFS), distant disease free survival (DDFS), overall disease free survival (ODFS) and overall survival (OS).
The univariate prognostic analysis of the pathological factors revealed that the pathological stage (OS: p=0.001, DDFS: p=0.040), lymph node metastases (OS: p=0.013), mitotic index (OS: p=0.026), tumor necrosis (DDFS: p=0.013, ODFS: p=0.021) and tumor size (OS: p=0.002) had a prognostic significance. The multivariate analysis demonstrated that the pathological stage (OS: p=0.021), tumor size (OS: p=0.044), lymph node status (DDFS: p=0.019, ODFS; p=0.041) and necrosis (ODFS: p=0.048) were independent prognostic factors.
Although many histopathological factors have recently been proposed as important prognostic markers, we only found significant results for mitotic index and tumor necrosis, as well as the well known parameters such as tumor stage and lymph node status. To the best of our knowledge, this is the first study evaluating such a wide range of morphological prognostic factors in lung SCC.
肺癌鳞状细胞癌(SCC)的新型组织病理学预后特征,如肿瘤芽生、有丝分裂率、肿瘤间质比、间质类型、间质炎症和坏死,已在文献中得到评估。在本研究中,评估了多种形态学特征在肺SCC中的预后价值。
本研究报告了76例接受完整手术切除的肺SCC患者。评估了肿瘤大小、肿瘤分期、淋巴结状态、淋巴管侵犯、组织病理学分级、有丝分裂计数、坏死、肿瘤芽生、肿瘤间质比、间质类型、间质淋巴细胞浆细胞反应以及间质浆细胞比例及其与预后的关系。对局部无病生存期(LDFS)、远处无病生存期(DDFS)、总无病生存期(ODFS)和总生存期(OS)的组织病理学标志物进行单因素和多因素分析。
病理因素的单因素预后分析显示,病理分期(OS:p = 0.001,DDFS:p = 0.040)、淋巴结转移(OS:p = 0.013)、有丝分裂指数(OS:p = 0.026)、肿瘤坏死(DDFS:p = 0.013,ODFS:p = 0.021)和肿瘤大小(OS:p = 0.002)具有预后意义。多因素分析表明,病理分期(OS:p = 0.021)、肿瘤大小(OS:p = 0.044)、淋巴结状态(DDFS:p = 0.019,ODFS;p = 0.041)和坏死(ODFS:p = 0.048)是独立的预后因素。
尽管最近提出了许多组织病理学因素作为重要的预后标志物,但我们仅发现有丝分裂指数和肿瘤坏死以及诸如肿瘤分期和淋巴结状态等众所周知的参数有显著结果。据我们所知,这是第一项评估肺SCC中如此广泛的形态学预后因素的研究。